Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Anti-LAG-3 Monoclonal Antibody BMS-986016

Known as: BMS-986016, BMS986016 
A monoclonal antibody directed against the inhibitor receptor lymphocyte activation gene-3 (LAG-3), with potential immunomodulating and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Pancreatic ductal adenocarcinoma (PDA) is notoriously aggressive and hard to treat. The tumour microenvironment (TME) in PDA is… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2019
2019
Immune checkpoint blockade using antibodies that target programmed-cell-death-1 (PD-1) or its ligand programmed-cell-death-ligand… Expand
Is this relevant?
2018
2018
Lymphocyte Activation Gene-3 (LAG-3) is a soluble protein and transmembrane protein receptor expressed on lymphocytes such as… Expand
  • figure 2
  • table 1
  • figure 4
  • figure 6
  • figure 7
Is this relevant?
2017
2017
9520Background: Signaling via LAG-3 and other T-cell inhibitory receptors (eg, PD-1) can lead to T-cell dysfunction and tumor… Expand
Is this relevant?
Review
2017
Review
2017
Tumor cells can evade immune surveillance through overexpressing the ligands of checkpoint receptors on tumor cells or adjacent… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Immunotherapies targeting the programmed death 1 (PD-1) coinhibitory receptor have shown great promise for a subset of patients… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?